Ebitda 更改
AbbVie USD 6.75B 433M 2023-09
ALKERMES USD 68.51M 189.7M 2023-09
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Cara Therapeutics USD -28839000 3.44M 2023-09
Eli Lilly USD 3.84B 1.88B 2023-09
J&J USD 6.46B 1.51B 2023-12
Merck USD 7.51B 11.02B 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
P&G USD 6.5B 26M 2023-12
Pacira USD 52.49M 12.98M 2023-12
Revance Therapeutics USD -41961000 20.01M 2023-09
Supernus Pharmaceuticals USD 40.87M 10.87M 2023-12



Revance Therapeutics - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.